Supply chains in the life sciences and healthcare industry will have an undoubted impact after the COVID-19 crisis. A significant restructuring of supply chains is imminent. Different stages of supply chains, from manufacturing and clinical development to product launches and after-market support will be impacted in different ways by the many changes unfolding now and in the coming times. This blog post discusses the short- and long-term impact of the COVID-19 crisis on supply chains in the LS&H industry and the many trends that need to materialize in order to mitigate the risks at present.
- Industry Left Col
- Industry Right Col